Fiduciary Management Inc’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Fiduciary Management Inc's DGX Position: Q3 2026 in Review
Fiduciary Management Inc reduced its Quest Diagnostics (DGX) stake by 47% in Q3 2026, selling an estimated $52.5M and leaving 256,367 shares worth $59.8M. The position accounts for 0.91% of the portfolio, ranked #48.
Fiduciary Management Inc first reported a position in DGX in Q4 2017 and has held it in 29 quarters since. The position peaked at $504M in Q3 2019. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Fiduciary Management Inc held 256,367 shares of Quest Diagnostics worth $59.8M as of Q3 2026.
- Fiduciary Management Inc sold 227,190 Quest Diagnostics shares in Q3 2026, an estimated $52.5M.
- Quest Diagnostics made up 0.91% of Fiduciary Management Inc's portfolio in Q3 2026, its #48 holding.
- Fiduciary Management Inc first reported a position in Quest Diagnostics in Q4 2017 and has held it in 29 quarters since.
- Fiduciary Management Inc's Quest Diagnostics position peaked at $504M in Q3 2019.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Fiduciary Management Inc's 13F filing for Q3 2026, filed 13 Nov 2026.